Your browser is no longer supported. Please, upgrade your browser.
Settings
PCRX Pacira Pharmaceuticals, Inc. daily Stock Chart
PCRX [NASD]
Pacira Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.10 Insider Own0.60% Shs Outstand40.91M Perf Week1.47%
Market Cap1.58B Forward P/E28.09 EPS next Y1.38 Insider Trans-44.49% Shs Float40.84M Perf Month-13.93%
Income-4.20M PEG- EPS next Q0.27 Inst Own- Short Float6.08% Perf Quarter-17.61%
Sales321.20M P/S4.93 EPS this Y-5.00% Inst Trans0.19% Short Ratio4.56 Perf Half Y4.53%
Book/sh7.35 P/B5.27 EPS next Y65.35% ROA-0.70% Target Price53.56 Perf Year-3.90%
Cash/sh9.45 P/C4.10 EPS next 5Y78.00% ROE-1.40% 52W Range26.95 - 55.00 Perf YTD-9.97%
Dividend- P/FCF58.04 EPS past 5Y9.10% ROI-5.20% 52W High-29.58% Beta1.67
Dividend %- Quick Ratio7.80 Sales past 5Y49.00% Gross Margin73.80% 52W Low43.71% ATR2.08
Employees489 Current Ratio8.70 Sales Q/Q23.90% Oper. Margin3.80% RSI (14)39.75 Volatility4.03% 5.86%
OptionableYes Debt/Eq0.95 EPS Q/Q91.70% Profit Margin-1.30% Rel Volume0.90 Prev Close38.34
ShortableYes LT Debt/Eq0.95 EarningsJan 31 BMO Payout- Avg Volume543.88K Price38.73
Recom2.60 SMA20-4.09% SMA50-13.53% SMA200-6.32% Volume489,737 Change1.02%
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
Apr-09-18Reiterated H.C. Wainwright Buy $45 → $48
Mar-21-18Reiterated Mizuho Neutral $44 → $31
Feb-16-18Downgrade Needham Buy → Hold
Jan-19-18Initiated Seaport Global Securities Buy $50
Jan-04-18Reiterated Canaccord Genuity Buy $42 → $46
Jan-03-18Initiated Leerink Partners Mkt Perform $46
Dec-18-17Initiated JP Morgan Neutral $47
Nov-29-17Downgrade Mizuho Buy → Neutral $53 → $44
Nov-09-17Resumed H.C. Wainwright Buy $52
Oct-26-17Downgrade Janney Neutral → Sell
Oct-19-17Reiterated Needham Buy $55 → $52
Sep-28-17Initiated Goldman Neutral $41
Sep-07-17Initiated Oppenheimer Perform
Aug-22-17Initiated Needham Buy $55
Aug-21-17Upgrade Janney Sell → Neutral
May-05-17Reiterated Mizuho Buy $57 → $54
Apr-13-17Initiated RBC Capital Mkts Outperform $58
Mar-23-17Reiterated Mizuho Buy $59 → $54
Mar-21-17Reiterated Barclays Overweight $54 → $59
Jan-17-19 07:06PM  Pacira's Study on Exparel Label Expansion Meets Endpoints Zacks
Jan-16-19 07:30AM  EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients GlobeNewswire
Jan-04-19 07:25AM  New Research Coverage Highlights LKQ, Pacira Pharmaceuticals, WellCare Health Plans, Masimo, Workday, and Potbelly Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-03-19 05:43PM  Cara (CARA) Up on IDMC's Recommendation to Continue Trial Zacks -9.52%
07:30AM  Pacira Reports Preliminary 2018 Net EXPAREL® Sales of $331 Million GlobeNewswire
Jan-02-19 11:39AM  An Intrinsic Calculation For Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) Shows Its 34.81% Undervalued Simply Wall St.
09:35AM  Pacira Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-12-18 07:30AM  New Retrospective Analysis Demonstrates Significant Reductions in Postsurgical Pain and Opioid Requirements with EXPAREL in Cesarean Section Patients GlobeNewswire
Dec-10-18 10:23AM  Zacks.com featured highlights include: Abercrombie & Fitch, Pacira Pharmaceuticals, Penumbra, Sprint and Salesforce.com Zacks
Dec-09-18 07:39PM  Pacira Pharmaceuticals Inc (PCRX): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-07-18 07:30AM  Pacira Pharmaceuticals to Present at the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-30-18 09:15AM  Lilly (LLY) Hits Fresh High: Is There Still Room to Run? Zacks
Nov-27-18 07:30AM  New Data Show EXPAREL Plays a Key Role in Achieving Significant Reductions in Opioid Use, Hospital Stay and Total Hospitalization Costs Following Painful Knee Replacement Surgery GlobeNewswire
Nov-23-18 01:11PM  Is Pacira Pharmaceuticals Incs (NASDAQ:PCRX) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-16-18 07:30AM  Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials GlobeNewswire
Nov-09-18 05:47PM  Edited Transcript of PCRX earnings conference call or presentation 1-Nov-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-08-18 08:20AM  Report: Developing Opportunities within Rayonier Advanced Materials, Health Insurance Innovations, Columbus McKinnon, A. O. Smith, Pacira Pharmaceuticals, and Altice Future Expectations, Projections Moving into 2018 GlobeNewswire
07:30AM  Pacira Pharmaceuticals to Present at Healthcare Conferences in November GlobeNewswire
Nov-05-18 10:38AM  Pacira (PCRX) Q3 Earnings and Revenues Surpass Estimates Zacks
Nov-02-18 02:12PM  Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL GlobeNewswire
Nov-01-18 08:56AM  Pacira: 3Q Earnings Snapshot Associated Press +6.69%
08:00AM  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-30-18 07:30AM  Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers GlobeNewswire
Oct-25-18 07:30AM  Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018 GlobeNewswire
Oct-17-18 08:25AM  Recent Analysis Shows Repligen, SpartanNash, AZUL SA, Pacira Pharmaceuticals, Ichor, and Scorpio Tankers Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-11-18 07:30AM  New Research Reveals Potency and Quantity of Opioids Prescribed for Postsurgical Pain Poses Danger to Patients, their Families and Friends GlobeNewswire
Sep-28-18 08:31AM  Aurinia Pharmaceuticals (AUPH) in Focus: Stock Moves 6.7% Higher Zacks
Sep-27-18 08:41AM  Corbus Pharmaceuticals (CRBP) in Focus: Stock Moves 6% Higher Zacks
08:37AM  Catalyst Pharmaceuticals (CPRX) Catches Eye: Stock Jumps 6.3% Zacks
Sep-26-18 11:14AM  Portola's (PTLA) Lymphoma Candidate Gets Orphan Drug Status Zacks
Sep-20-18 11:40AM  Molecular Templates Surges 50%, Inks Cancer Deal With Takeda Zacks
08:53AM  Implied Volatility Surging for Pacira Pharmaceuticals (PCRX) Stock Options Zacks
08:00AM  Today's Research Reports on Trending Tickers: Pacira Pharmaceuticals and OPKO Health ACCESSWIRE
Sep-19-18 10:28AM  Are Pacira Pharmaceuticals Incs (NASDAQ:PCRX) Interest Costs Too High? Simply Wall St. +7.31%
Sep-18-18 11:18AM  United Therapeutics In-Licenses Rights to IPF Candidate Zacks
Sep-14-18 08:28PM  Edited Transcript of PCRX earnings conference call or presentation 3-May-18 12:30pm GMT Thomson Reuters StreetEvents
03:55PM  Pacira Shares Look Expensive, Stifel Says In Bearish Initiation Benzinga
Sep-13-18 09:13AM  Spectrum Pharma Includes First-Line NSCLC in Poziotinib Study Zacks
Sep-11-18 08:55AM  Endocyte (ECYT) Soars: Stock Adds 11.4% in Session Zacks
Sep-05-18 04:44PM  Biogen Begins Phase III Study on Ischemic Stroke Candidate Zacks
Aug-27-18 09:27AM  Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe Zacks
07:54AM  Edited Transcript of PCRX earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 07:35AM  Consolidated Research: 2018 Summary Expectations for SpartanNash, Encana, Hilltop, Pacira Pharmaceuticals, Menlo Therapeutics, and Rayonier Advanced Materials Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-22-18 11:31AM  Pacira (PCRX) Rides High on Robust Exparel Performance Zacks
Aug-13-18 08:50AM  Pacira Pharmaceuticals (PCRX): Moving Average Crossover Alert Zacks
Aug-08-18 07:30AM  Pacira Pharmaceuticals to Present at the 2018 Wedbush Pacgrow Healthcare Conference GlobeNewswire
Aug-06-18 11:18AM  Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-02-18 10:10AM  Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates Zacks +5.91%
09:07AM  Pacira: 2Q Earnings Snapshot Associated Press
08:00AM  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-31-18 09:26AM  Zoetis (ZTS) Gears Up for Q2 Earnings: What's in Store? Zacks
Jul-30-18 07:10AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
Jul-26-18 12:31PM  Why Pacira Pharmaceuticals Stock Is on the Rise Today Motley Fool +12.55%
Jul-25-18 07:30AM  Pacira to Report Second Quarter 2018 Financial Results on Thursday August 2, 2018 GlobeNewswire
Jul-16-18 05:25PM  Pacira Focused on Exparel Development Amid Competition Zacks
Jul-11-18 09:37AM  Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2 Zacks
Jul-10-18 07:30AM  Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018 GlobeNewswire
Jul-02-18 07:25AM  Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks ACCESSWIRE
Jun-27-18 11:31AM  Investors Are Undervaluing Pacira Pharmaceuticals Inc (NASDAQ:PCRX) By 43.7% Simply Wall St. -5.27%
Jun-22-18 06:52AM  Heron Therapeutics stock rockets 30% on high hopes for post-surgery pain treatment MarketWatch
Jun-19-18 07:30AM  Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China GlobeNewswire
Jun-18-18 08:20AM  Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown-Forman, Pacira Pharmaceuticals, Team, and Solaris Oilfield Infrastructure Fundamental Analysis, Key Performance Indications GlobeNewswire
Jun-15-18 07:30AM  Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL® GlobeNewswire
Jun-13-18 06:45AM  MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS) Collaborative to Minimize Opioid Use Business Wire
Jun-04-18 05:46AM  Pacira Pharmaceuticals (PCRX) Up 3.5% Since Earnings Report: Can It Continue? Zacks
May-31-18 07:30AM  Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference GlobeNewswire
May-24-18 07:15AM  Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks ACCESSWIRE
May-03-18 09:55AM  Pacira: 1Q Earnings Snapshot Associated Press
08:00AM  Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 07:30AM  Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May GlobeNewswire
Apr-26-18 07:30AM  Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call GlobeNewswire
Apr-20-18 07:30AM  Detailed Research: Economic Perspectives on PacWest, HD Supply, Limelight Networks, Clean Harbors, Versartis, and Pacira Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-13-18 03:20PM  Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III Zacks
Apr-09-18 05:15PM  FDA Okays Label Expansion of Pacira's Exparel's, Stock Up Zacks
11:24AM  Heres Why The Latest News Is A Big Deal For Pacira Pharmaceuticals Market Exclusive
10:13AM  Company News For Apr 9, 2018 Zacks
08:37AM  Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 12.9% in Session Zacks
Apr-06-18 05:36PM  Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia GlobeNewswire +12.88%
04:34PM  Why SUPERVALU, GOL, and Pacira Pharmaceuticals Jumped Today Motley Fool
Apr-02-18 04:58AM  Pacira Pharmaceuticals (PCRX) Down 4.7% Since Earnings Report: Can It Rebound? Zacks -11.72%
Mar-20-18 08:05AM  Pacira Pharmaceuticals, Upcoming PDUFA Date, Analysts Review and Target, FYE Financials ACCESSWIRE
Mar-19-18 05:47PM  Why Heron Therapeutics Stock Soared Today Motley Fool
05:26PM  This Biotech Stock Catapulted After Its Pain Drug Trumped A Key Rival Investor's Business Daily
Mar-09-18 07:00AM  Free Post Earnings Research Report: Lannett's Quarterly Earnings Advanced 15.22% ACCESSWIRE
Mar-06-18 07:30AM  Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference GlobeNewswire
Mar-02-18 02:33PM  Pacira (PCRX) Posts Earnings in Q4, Revenues in Line Zacks
Feb-28-18 10:56PM  Edited Transcript of PCRX earnings conference call or presentation 28-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
10:00AM  Pacira tops Street 4Q forecasts Associated Press
08:00AM  Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update GlobeNewswire
06:40AM  Pacira Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-18 07:30AM  University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery GlobeNewswire
Feb-22-18 04:00PM  Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call GlobeNewswire
Feb-20-18 10:41AM  Heres Whats Moving Apricus Biosciences And Pacira Pharmaceuticals Market Exclusive
Feb-16-18 04:15PM  This Biotech Stock May Need Anesthesia After Collapsing Nearly 20% Investor's Business Daily -16.48%
07:30AM  Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference GlobeNewswire
Feb-15-18 05:26PM  FDA Panel Votes 6-4 Against Recommending This Biotech's Pain Blocker Investor's Business Daily
03:34PM  Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia GlobeNewswire
08:15AM  Consolidated Research: 2018 Summary Expectations for Pacira Pharmaceuticals, Wabash National, Spirit Airlines, Praxair, Altice, and Gap Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-14-18 04:39PM  What You Must Know About Pacira Pharmaceuticals Incs (NASDAQ:PCRX) Financial Strength Simply Wall St.
01:28PM  Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company's lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STACK DAVID MCEO and ChairmanDec 18Option Exercise3.5512,00042,600133,683Dec 20 04:30 PM
Wicki AndreasDirectorDec 13Sale46.188,720402,692950,362Dec 14 05:47 PM
Wicki AndreasDirectorDec 12Sale47.845,807277,803959,082Dec 14 05:47 PM
PACE GARY WDirectorNov 19Buy46.184,500207,81032,819Nov 21 04:07 PM
Wicki AndreasDirectorNov 19Sale47.0899046,605964,889Nov 21 05:19 PM
Wicki AndreasDirectorNov 16Sale46.8325,6001,198,775965,879Nov 19 07:17 PM
Wicki AndreasDirectorNov 15Sale47.6444,8982,138,811991,479Nov 19 07:17 PM
STACK DAVID MCEO and ChairmanNov 15Sale47.3915,000710,801121,683Nov 19 04:06 PM
Wicki AndreasDirectorNov 12Sale49.835,478272,9801,036,377Nov 14 08:09 PM
Wicki AndreasDirectorNov 09Sale50.2390645,5081,041,855Nov 13 08:35 PM
Wicki AndreasDirectorNov 08Sale51.1357,3392,931,5831,042,761Nov 13 08:35 PM
PACE GARY WDirectorNov 07Buy51.294,000205,16028,319Nov 09 04:30 PM
Riker Lauren BullaroVice President, FinanceNov 02Option Exercise10.341,00010,34011,474Nov 06 04:25 PM
Riker Lauren BullaroVice President, FinanceNov 02Sale54.351,00054,35010,474Nov 06 04:25 PM
STACK DAVID MCEO and ChairmanOct 11Option Exercise2.9045,000130,650136,683Oct 15 04:30 PM
Riker Lauren BullaroVice President, FinanceSep 24Option Exercise10.341,00010,34011,474Sep 26 05:13 PM
Riker Lauren BullaroVice President, FinanceSep 24Sale50.701,00050,70010,474Sep 26 05:13 PM
Kronenfeld Mark A.DirectorAug 28Buy44.611,00044,6118,577Aug 30 04:34 PM
Riker Lauren BullaroVice President, FinanceAug 22Sale44.481,66774,14810,474Aug 24 04:59 PM
STACK DAVID MCEO and ChairmanAug 15Option Exercise10.5814,091149,079124,745Aug 16 05:14 PM
STACK DAVID MCEO and ChairmanAug 15Sale47.3233,0621,564,43291,683Aug 16 05:14 PM
Williams Kristen MarieCAO and General CounselAug 14Sale47.044,773224,52222,374Aug 16 05:12 PM
STACK DAVID MCEO and ChairmanJun 07Sale36.879,791360,98482,040Jun 08 05:03 PM
STACK DAVID MCEO and ChairmanJun 06Sale35.618,615306,78091,831Jun 08 05:03 PM
Williams Kristen MarieCAO and General CounselJun 04Sale33.022,04067,36119,272Jun 06 08:11 PM
Weiland Robert J.Chief Commercial OfficerJun 04Sale33.0237312,3165,088Jun 06 08:11 PM
Scranton RichardChief Scientific OfficerJun 04Sale33.021,36745,13812,226Jun 06 08:09 PM
Reinhart Charles A. IIIChief Financial OfficerJun 04Sale33.0270823,3788,042Jun 06 08:08 PM
Riker Lauren BullaroVice President, FinanceJun 04Sale33.0280126,4499,641Jun 06 08:09 PM
HASTINGS PAUL JDirectorJun 04Sale33.9077126,1372,747Jun 06 08:07 PM
STACK DAVID MCEO and ChairmanMay 15Option Exercise7.6225,000190,450125,446May 17 07:17 PM
STACK DAVID MCEO and ChairmanMay 15Sale33.7925,000844,781100,446May 17 07:17 PM